CellCarta Overview
- Founded
-
2000
- Status
-
Private
- Employees
-
138
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
10
CellCarta General Information
Description
Provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industry. The company operates two proprietary immune monitoring platforms that offer proprietary multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses while its proteomics business unit, as well as gel-free, label-free mass spectrometry (MS) provide a comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.
Contact Information
Website
www.cellcarta.com
Formerly Known As
Caprion Proteomics, Caprion Proteomics GP, Caprion-HistoGeneX, Caprion Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- 201 President Kennedy Avenue
- Suite 3900
- Montreal, Quebec H2X 3Y7
- Canada
+1 (514) 000-0000
CellCarta Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CellCarta Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industry. The company ope
Discovery Tools (Healthcare)
Montreal, Canada
138
As of 2021
0000
0000-00-00
000000000000
0000 0
irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000000000000
Rockville, MD
000
As of 0000
0000000000
000000
velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Rockville, MD
000
As of 0000
00000
000000000
00000
Add Comparison
CellCarta Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Meso Scale Discovery | Corporation | Rockville, MD | 000 | 0000000000 | ||
| 00000000000 | Formerly VC-backed | Rockville, MD | 000 | 00000 | 000000000 | 00000 |
| 000000 | Venture Capital-Backed | Cologne, Germany | 00 | 0000 | 0000000000 0 | 0000 |
| 00000 0000 | Corporation | Hyderabad, India | 0000 | |||
| 0000000 | Corporate Backed or Acquired | Austin, TX | 0000 | 000.00 | 000000&0 | 000.00 |
CellCarta Patents
CellCarta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160266140-A1 | Brucellosis, q-fever, and lyme disease biomarkers and uses thereof | Granted | 21-Mar-2013 | 00000000000 | 0 |
| CA-2907023-A1 | Brucellosis, q-fever, and lyme disease biomarkers and uses thereof | Pending | 21-Mar-2013 | 00000000000 | |
| US-10191063-B2 | Brucellosis, q-fever, and lyme disease biomarkers and uses thereof | Active | 21-Mar-2013 | 00000000000 | 0 |
| AU-2014233935-A1 | Brucellosis, q-fever, and lyme disease biomarkers and uses thereof | Abandoned | 21-Mar-2013 | 00000000000 | |
| EP-2976638-A2 | Brucellosis, q-fever, and lyme disease biomarkers and uses thereof | Granted | 21-Mar-2013 | G01N33/6848 |
CellCarta Executive Team (18)
CellCarta Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000000 | Arsenal Capital Partners | Chairman | 000 0000 |
| 000000 0000000 | Arsenal Capital Partners | Board Member | 000 0000 |
| 00000 0000000 00.0 | Self | Board Member | 000 0000 |
| 0000000 0000 | Arsenal Capital Partners | Board Member | 000 0000 |
| 0000000 000000 | CellCarta | Board Member | 000 0000 |
CellCarta Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
CellCarta Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CellCarta Investments (10)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 17-May-2022 | 0000000000 | Buildings and Property | 0000000 0 | |
| 0000000000 | 14-Dec-2021 | 0000000000 | Biotechnology | 000000 00 | |
| 000000 000000 | 11-May-2021 | 0000000000 | Biotechnology | 000000 00 | |
| 000000 000000 | 12-Jan-2021 | 0000000000 | Biotechnology | 000000 00 | |
| Clinical Logistics | 07-Jan-2021 | Buyout/LBO | Medical Supplies | 000000 00 |
CellCarta Subsidiaries (5)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Reveal Biosciences | Biotechnology | San Diego, CA | 2012 |
| 0000000000 | Biotechnology | Zwijnaarde, Belgium | 0000 |
| 000000 00000000000 | Biotechnology | Lake Forest, CA | 0000 |
| 00000000 000000000 | Medical Supplies | Dartmouth, Canada | 0000 |
| 0000000000 | Laboratory Services (Healthcare) | Antwerp, Belgium | 0000 |